Ceradis secures growth financing and strengthens its shareholder base

Ceradis B.V. recently announced the closing of an equity financing round of EUR 9 million (USD 10 million) by Waterman Ventures and Pymwymic, along with existing shareholder Van Herk Investments.

The proceeds of this financing will be used to commercialize its blockbuster product, CeraMax, a biofungicide effective against various diseases for a multitude of crops, which will be available on the US market from 2020. Ceradis will also advance several of its R&D products under development towards registration and commercial use, and strengthen its team.

Willem-Jan Meulemeesters, Ceradis CEO: “We are proud that our technologies and products are being validated by the market, in partnership with several of the largest global crop protection companies. We are equally proud to announce this investment, enabling us to scale further. We look forward to working with this strong group of current and new investors to realize our technologies’ potential.”

Peter Rutgers, Waterman Ventures: “With its versatile technologies and a very strong product pipeline, we are very excited about joining Ceradis. Ceradis has already proven that its biofungicides are as effective as today’s chemical products. Ceradis’ technologies have the same potential in other pesticide classes such as herbicides and insecticides. This company can truly have a positive impact on crop producers and consumers alike.”

Pieter Vis, Pymwymic: “Consumer and regulatory pressure to use less chemicals in crop protection is getting ever stronger and Ceradis has the solutions farmers need. We as impact investors are very excited about joining Ceradis and helping farmers feed the world in a sustainable way.”